{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:45:20Z","timestamp":1791585920986,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10147-020-01615-y","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T09:04:47Z","timestamp":1578560687000},"page":"885-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-2502","authenticated-orcid":false,"given":"Omar","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"issue":"Suppl 1","key":"1615_CR1","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0378-5122(02)00149-4","volume":"43","author":"MM Brood-van Zanten","year":"2002","unstructured":"Brood-van Zanten MM, Barentsen R, van der Mooren MJ (2002) Hormone replacement therapy and surveillance considerations. Maturitas. 43(Suppl 1):S57\u201367","journal-title":"Maturitas."},{"issue":"1","key":"1615_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/cmt.5.1.3.14","volume":"5","author":"F Al-Azzawi","year":"2002","unstructured":"Al-Azzawi F, Wahab M (2002) Estrogen and colon cancer: current issues. Climacteric. 5(1):3\u201314","journal-title":"Climacteric."},{"issue":"3","key":"1615_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Investigators WGftWsHI","year":"2002","unstructured":"Investigators WGftWsHI (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal womenprincipal results from the women's health initiative randomized controlled trial. JAMA 288(3):321\u2013333","journal-title":"JAMA"},{"issue":"6","key":"1615_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3961\/jpmph.15.054","volume":"48","author":"J-M Bae","year":"2015","unstructured":"Bae J-M, Kim EH (2015) Hormonal replacement therapy and the risk of lung cancer in women: an adaptive meta-analysis of cohort studies. J Prev Med Public Health 48(6):280\u2013286","journal-title":"J Prev Med Public Health"},{"issue":"5","key":"1615_CR5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/1055-9965.EPI-10-1325","volume":"20","author":"LA Brinton","year":"2011","unstructured":"Brinton LA, Gierach GL, Andaya A et al (2011) Reproductive and hormonal factors and lung cancer risk in the NIH-AARP diet and health study cohort. Cancer Epidemiol Biomarkers Prev. 20(5):900\u2013911","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"17","key":"1615_CR6","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1001\/jama.2011.1591","volume":"306","author":"MM Oken","year":"2011","unstructured":"Oken MM, Hocking WG, Kvale PA et al (2011) Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal, and ovarian (PLCO) randomized trial. JAMA 306(17):1865\u20131873","journal-title":"JAMA"},{"issue":"3","key":"1615_CR7","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/crj.12632","volume":"12","author":"O Abdel-Rahman","year":"2018","unstructured":"Abdel-Rahman O (2018) Changing epidemiology of elderly small cell lung cancer patients over the last 40 years; a SEER database analysis. Clin Respir J. 12(3):1093\u20131099","journal-title":"Clin Respir J."},{"issue":"6","key":"1615_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/17476348.2019.1615887","volume":"13","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O (2019) Impact of current versus former smoking status on the outcomes of non-metastatic non-small cell lung cancer treated with upfront surgery; findings from the National Lung Screening Trial. Expert Rev Respir Med. 13(6):585\u2013591","journal-title":"Expert Rev Respir Med."},{"issue":"1","key":"1615_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1158\/1078-0432.CCR-0911-3","volume":"10","author":"MB Schabath","year":"2004","unstructured":"Schabath MB, Wu X, Vassilopoulou-Sellin R et al (2004) Hormone replacement therapy and lung cancer risk. A case-control analysis. Clin Cancer Res 10(1):113\u2013123","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1615_CR10","first-page":"565","volume":"102","author":"H Olsson","year":"2003","unstructured":"Olsson H, Bladstrom A, Ingvar C (2003) Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol. 102(3):565\u2013570","journal-title":"Obstet Gynecol."},{"issue":"7","key":"1615_CR11","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/JTO.0000000000000558","volume":"10","author":"AG Schwartz","year":"2015","unstructured":"Schwartz AG, Ray RM, Cote ML et al (2015) Hormone use, reproductive history, and risk of lung cancer: the Women's Health Initiative Studies. J Thorac Oncol. 10(7):1004\u20131013","journal-title":"J Thorac Oncol."},{"issue":"1","key":"1615_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/0029-7844(95)00358-4","volume":"87","author":"B Ettinger","year":"1996","unstructured":"Ettinger B, Friedman GD, Bush T et al (1996) Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 87(1):6\u201312","journal-title":"Obstet Gynecol."},{"key":"1615_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.steroids.2016.12.005","volume":"118","author":"W Li","year":"2017","unstructured":"Li W, Lin X, Wang R et al (2017) Hormone therapy and lung cancer mortality in women: systematic review and meta-analysis. Steroids 118:47\u201354","journal-title":"Steroids"},{"issue":"11","key":"1615_CR14","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/aje\/kwn257","volume":"168","author":"JM Weiss","year":"2008","unstructured":"Weiss JM, Lacey JV Jr, Shu XO et al (2008) Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol. 168(11):1319\u20131325","journal-title":"Am J Epidemiol."},{"issue":"3","key":"1615_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1158\/1055-9965.EPI-08-0892","volume":"18","author":"A Seow","year":"2009","unstructured":"Seow A, Koh WP, Wang R et al (2009) Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev. 18(3):821\u2013827","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"13","key":"1615_CR16","first-page":"2979","volume":"56","author":"T Shimada","year":"1996","unstructured":"Shimada T, Hayes CL, Yamazaki H et al (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56(13):2979\u20132984","journal-title":"Cancer Res."},{"key":"1615_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/17476348.2019.1656532","volume":"13","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O (2019) Pre-diagnostic body mass index trajectory in relationship to lung cancer incidence and mortality; findings from the PLCO Trial. Expert Rev Respir Med 13:1029\u20131035","journal-title":"Expert Rev Respir Med"},{"issue":"6","key":"1615_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/humupd\/dmi028","volume":"11","author":"JA Collins","year":"2005","unstructured":"Collins JA, Blake JM, Crosignani PG (2005) Breast cancer risk with postmenopausal hormonal treatment. Hum Reprod Update. 11(6):545\u2013560","journal-title":"Hum Reprod Update."},{"key":"1615_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-3-030-11355-1_19","volume-title":"Sex steroids' effects on brain, heart and vessels: volume 6: Frontiers in Gynecological Endocrinology","author":"TS Mikkola","year":"2019","unstructured":"Mikkola TS (2019) Cardiovascular mortality risk and HRT. In: Brinton RD, Genazzani AR, Simoncini T, Stevenson JC (eds) Sex steroids' effects on brain, heart and vessels: volume 6: Frontiers in Gynecological Endocrinology. Springer International Publishing, Cham, pp 271\u2013274"},{"issue":"7","key":"1615_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1525-1497.2004.30281.x","volume":"19","author":"SR Salpeter","year":"2004","unstructured":"Salpeter SR, Walsh JME, Greyber E et al (2004) Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med. 19(7):791\u2013804","journal-title":"J Gen Intern Med."}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01615-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-020-01615-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01615-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T01:35:55Z","timestamp":1610069755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-020-01615-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1615"],"URL":"https:\/\/doi.org\/10.1007\/s10147-020-01615-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"5 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All included patients in the PLCO trial signed informed consent. IRBs of all participating centers have approved the study prior to starting the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}